Harvard scientists create first disease-specific human stem cell lines

Kevin Eggan, an assistant professor of stem-cell and regenerative biology, announced in Science that he had used the technique to create...

Two teams of researchers within the Harvard Stem Cell Institute (HSCI) announced in the last week that they have created disease-specific stem-cell lines using adult cells from human patients. The technique they used to achieve this, pioneered by Shinya Yamanaka of Kyoto University in 2006, employs viruses to reset adult cells to a primordial state. These induced pluripotent stem cells (iPS cells), as they are known, can then be prodded to differentiate into more specialized kinds of cells.

Kevin Eggan, an assistant professor of stem-cell and regenerative biology, announced in Science that he had used the technique to create motor neurons from the cells of an 82-year-old patient with ALS, or Lou Gehrig's disease. George Daley, an associate professor of biological chemistry and molecular pharmacology and of pediatrics, writing in Cell, announced that his laboratory had created 20 stem-cell lines representing a variety of afflictions, from "bubble-boy" disease to Parkinson's.

Douglas Melton, who co-directs the Harvard Stem Cell Institute, announced that HSCI would create a "core laboratory," dedicated to the iPS technique, that could be shared among the institute's researchers. He further announced that HSCI would distribute these new disease-bearing stem-cell lines, for a nominal fee, to researchers throughout the world.

The iPS cell lines created by Eggan and Daley will allow researchers to study the development of these diseases in a petri dish, making them phenomenally powerful tools for research. But the viruses and genes used in the Yamanaka iPS technique can cause cancer, so these cell lines cannot be used in human therapy.

Researchers worldwide emphasized that although the iPS technique might at first glance seem to obviate the need for working with embryonic stem cells derived from fertilized human eggs, those cells continue to remain important to the field of stem-cell research.

For background on stem-cell research at Harvard, see this magazine’s previous cover article “Stem-Cell Science.” Click here to read a copy of the Harvard press release about the discovery. Read more about Kevin Eggan’s work here.

Related topics

You might also like

To Promote Healthy Habits in Patients, Start with the Doctors

Why Harvard Medical School is training physicians to think more like coaches

Harvard Couple Aim to Cure Prion Diseases

The stakes are high for this husband and wife: one of them will die if they don’t find a cure.

Don’t Call Stephanie Pierce A Paleontologist

From competing in youth gymnastics to studying tetrapods, the Harvard curator has always chased her curiosity.

Most popular

Six from Harvard Named Rhodes Scholars

Four Americans and two Canadians will begin studies at Oxford next fall.

These Harvard Graduates Are Candidates for Sainthood

For advocacy and benevolence, three late alumni are reportedly in line for the Catholic Church’s highest honor.

How Philosophy at Harvard Saved Itself

As humanities shrink across higher education, one department is flourishing. Is its success a fluke, or a roadmap?

Explore More From Current Issue

St. Peter's Basilica at sunset, illuminated by purple and orange sky reflections in the river.

For advocacy and benevolence, three late alumni are reportedly in line for the Catholic Church’s highest honor.

Collage of three photos of an athlete in a triathlon: one swimming, one cycling, one running, in sports attire.

The Harvard triathlete and coach says she helps normal people to “do extraordinary things.”

Panoramic view of Harvard University with autumn foliage and a river under a cloudy sky.

The University is expanding industry ties and investing its own funds to support research, but neither will replace lost federal dollars.